Pseudomonas aeruginosa and Staphylococcus aureus are the two most prevalent bacteria
species in the lungs of cystic fibrosis (CF) patients and are associated with poor clinical …

Pseudomonas aeruginosa is a major pathogen in the lungs of cystic fibrosis (CF) patients.
However, it is now recognised that a diverse microbial community exists in the airways …

Chronic coinfections of Staphylococcus aureus and Pseudomonas aeruginosa frequently
fail to respond to antibiotic treatment, leading to significant patient morbidity and mortality …

We investigate the effect of bacteriophage infection and antibiotic treatment on the
coordination of swarming, a collective form of flagellum-and pilus-mediated motility in …

The airways of individuals with cystic fibrosis (CF) are abundantly colonised by
Staphylococcus aureus and Pseudomonas aeruginosa. Co-infecting hypoxic regions of …

Gender differences in chronic respiratory disease, including cystic fibrosis and non-cystic
fibrosis bronchiectasis are clinically apparent and of increasing importance. Differences in …

Antibiotic-resistant Pseudomonas aeruginosa infections are the primary cause of mortality in
people with cystic fibrosis (CF). Yet, it has only recently become appreciated that resistance …

Background Pseudomonas species are common on food, but their contribution to the
antimicrobial resistance gene (ARG) burden within food or as a source of clinical infection is …

Bacterial opportunistic pathogens are feared for their difficult-to-treat nosocomial infections
and for causing morbidity in immunocompromised patients. Here, we study how such a …

The sustained misuse and overuse of antibacterial agents is accelerating the emergence of
antimicrobial resistance (AMR), which is becoming one of the major threats to public health …